Trial Profile
Phase III trial of tesetaxel first-line therapy in advanced gastric cancer
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase III
Latest Information Update: 05 Aug 2021
Price :
$35
*
At a glance
- Drugs Tesetaxel (Primary)
- Indications Gastric cancer
- Focus Registrational; Therapeutic Use
- Sponsors Genta (CEASED)
- 04 Jul 2011 New trial record
- 29 Jun 2011 A phase I/II trial (NCT01348009) will be a 'run-in' for this trial, according to a Genta media release.